We are live on ! Find out more
Jefferies Financial Group

Jefferies Financial Group Portfolio holdings

AUM $13.5B Turnover 52.85%
1-Year Est. Return 36.68%
 

Jefferies Financial Group is the investment banking and capital markets company that was known as Leucadia National until 2018, when it took the name of the bank it merged with in 2013. Leucadia traces back to Ian Cumming and Joseph Steinberg, Harvard Business School graduates who started out at the investment bank Carl Marks & Company and in 1979 took control of Talcott National, renaming it Leucadia the next year. As a holding company it bought and resold businesses, such as the insurer Colonial Penn, acquired in 1991 and sold in two pieces in 1997, and the telecoms company WilTel, acquired in 2003 and sold in 2005. Jefferies itself grew from a small equities trading shop into a full-service investment bank, and Richard Handler became chief executive of the combined company in 2013.

This Fund
S&P 500
This Quarter Est. Return
+3.06%
1 Year Est. Return
+36.68%
3 Year Est. Return
+146.37%
5 Year Est. Return
+81.72%
10 Year Est. Return
+581.29%
AUM
$13.5B
AUM Growth
-$1.68B
Cap. Flow
-$3.53B
Cap. Flow %
-26.13%
Top 10 Hldgs %
33.68%
Holding
1,968
New
337
Increased
289
Reduced
401
Closed
703
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1 year
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
1.1 years
Top 20 Avg Time Held Equity only
0.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.53%
2 Healthcare 11.13%
3 Technology 8.29%
4 Industrials 4.73%
5 Financials 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WULF icon
1076
CALL
TeraWulf
WULF
$5.85B
$111K ﹤0.01%
7,500
-138,700
-95% -$2.43M
2025 Q4
3 quarters
STLN icon
1077
Starling Oncology
STLN
$347M
$110K ﹤0.01%
+17,445
New +$104K
2026 Q3
0 quarters
DELL icon
1078
Dell
DELL
$205B
$107K ﹤0.01%
198
-17,234
-99% -$8.1M
2025 Q4
3 quarters
DERM icon
1079
Journey Medical
DERM
$110M
$106K ﹤0.01%
15,500
-1,097
-7% -$7.64K
2026 Q2
1 quarter
EVH icon
1080
PUT
Evolent Health
EVH
$523M
$106K ﹤0.01%
+30,300
New +$134K
2026 Q3
0 quarters
FLL icon
1081
Full House Resorts
FLL
$14.5M
$105K ﹤0.01%
73,703
– –
2024 Q1
10 quarters
TMCI icon
1082
Treace Medical Concepts
TMCI
$291M
$101K ﹤0.01%
22,800
-3,791
-14% -$17K
2026 Q2
1 quarter
NUAI icon
1083
New Era Energy & Digital
NUAI
$450M
$98.4K ﹤0.01%
+14,648
New +$78K
2026 Q3
0 quarters
CCL icon
1084
Carnival
CCL
$37.9B
$97.1K ﹤0.01%
3,957
-21,571
-84% -$552K
2024 Q4
7 quarters
LGCY icon
1085
Legacy Education
LGCY
$103M
$96.7K ﹤0.01%
+10,000
New +$110K
2026 Q3
0 quarters
OLMA icon
1086
Olema Oncology
OLMA
$633M
$95K ﹤0.01%
11,000
– –
2025 Q4
3 quarters
MRLN icon
1087
Merlin Inc
MRLN
$93M
$94K ﹤0.01%
50,000
– –
2026 Q2
1 quarter
TUSK icon
1088
Mammoth Energy Services
TUSK
$150M
$92.3K ﹤0.01%
+32,500
New +$97.6K
2026 Q3
0 quarters
GRAB icon
1089
Grab
GRAB
$12.8B
$92.1K ﹤0.01%
29,600
-106,680
-78% -$369K
2025 Q4
3 quarters
DH icon
1090
Definitive Healthcare
DH
$140M
$90.5K ﹤0.01%
+100,000
New +$82K
2026 Q3
0 quarters
MARA icon
1091
PUT
MARA Holdings
MARA
$2.49B
$85K ﹤0.01%
7,500
– –
2025 Q1
6 quarters
NEOV icon
1092
NeoVolta
NEOV
$138M
$84.5K ﹤0.01%
+32,500
New +$95.4K
2026 Q3
0 quarters
GCTS icon
1093
GCT Semiconductor Holding
GCTS
$107M
$83.5K ﹤0.01%
39,400
– –
2026 Q2
1 quarter
HURA icon
1094
TuHURA Biosciences
HURA
$89.2M
$82.7K ﹤0.01%
39,400
-2,533
-6% -$5.51K
2026 Q2
1 quarter
CCJ icon
1095
Cameco
CCJ
$28.1B
$79.3K ﹤0.01%
+915
New +$86.2K
2026 Q3
0 quarters
AMLX icon
1096
Amylyx Pharmaceuticals
AMLX
$3.54B
$72.8K ﹤0.01%
+2,500
New +$66.3K
2026 Q3
0 quarters
BMNR icon
1097
PUT
BitMine Immersion Technologies
BMNR
$9.9B
$71.4K ﹤0.01%
2,700
– –
2025 Q4
3 quarters
INDI icon
1098
indie Semiconductor
INDI
$448M
$70.5K ﹤0.01%
24,096
– –
2025 Q3
4 quarters
KULR icon
1099
KULR Technology Group
KULR
$71.3M
$68.1K ﹤0.01%
26,900
-2,702
-9% -$7.32K
2026 Q2
1 quarter
IMDX icon
1100
Insight Molecular Diagnostics
IMDX
$58.2M
$65K ﹤0.01%
18,100
– –
2026 Q2
1 quarter

Similar funds

Jefferies Financial Group's Q3 2026 Portfolio in Review

As of Q3 2026, Jefferies Financial Group held 1,968 positions worth $13.5B, down 11% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jefferies Financial Group withdrew a net $3.53B in Q3 2026, closing 703 positions and reducing 401 holdings. Its most notable exit was PTC Therapeutics, an estimated $111M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Jefferies Financial Group opened a new position in Emcor worth $40.1M.

  • Jefferies Financial Group's largest Q3 2026 buy was Emcor: 53,175 shares worth $40.1M.
  • Jefferies Financial Group added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2026, an estimated $204M increase.
  • Jefferies Financial Group's biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $640M.
  • Jefferies Financial Group fully exited PTC Therapeutics in Q3 2026, selling an estimated $111M.
  • Jefferies Financial Group's ten largest holdings make up 34% of its $13.5B portfolio in Q3 2026.
  • Jefferies Financial Group opened 337 new positions and closed 703 in Q3 2026.
  • Jefferies Financial Group's portfolio value fell 11% quarter-over-quarter to $13.5B.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.